The latest price target for Immunocore Holdings (NASDAQ:IMCR) was reported by HC Wainwright & Co. on April 20, 2026. The analyst firm set a price target for $100.00 expecting IMCR to rise to within 12 months (a possible 246.62% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Immunocore Holdings (NASDAQ:IMCR) was provided by HC Wainwright & Co., and Immunocore Holdings reiterated their buy rating.

There is no last upgrade for Immunocore Holdings

The last downgrade for Immunocore Holdings PLC happened on March 16, 2026 when Jefferies changed their price target from $48 to $33 for Immunocore Holdings PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immunocore Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immunocore Holdings was filed on April 20, 2026 so you should expect the next rating to be made available sometime around April 20, 2027.

While ratings are subjective and will change, the latest Immunocore Holdings (IMCR) rating was a reiterated with a price target of $100.00 to $100.00. The current price Immunocore Holdings (IMCR) is trading at is $28.85, which is out of the analyst’s predicted range.